4D-150 IVT (3E10 vg/eye)
4D-150-C004
Phase 3 mab active
Quick answer
4D-150 IVT (3E10 vg/eye) for Neovascular Age-Related Macular Degeneration (nAMD) is a Phase 3 program (mab) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Neovascular Age-Related Macular Degeneration (nAMD)
- Phase
- Phase 3
- Modality
- mab
- Status
- active